GlassScriptPhysician profile
William Posligua
NPI 1902080484
$12,173.78
in general payments reported to CMS, 2019-2025
44 companies · $1,054 in 2025
The $1,054 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,587 · 2020: $1,613 · 2021: $1,983 · 2022: $2,017 · 2023: $1,892 · 2024: $2,027 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,956 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,956.14 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,262.88 | 2019-2025 | Lifevest |
| Amgen INC. | $1,161.66 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $1,157.27 | 2019-2025 | Farxiga |
| Abbott Laboratories | $1,147.22 | 2019-2025 | Xience Skypoint, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $972.34 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $903.44 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $874.37 | 2021-2025 | Verquvo |
| Amarin Pharma, INC. | $711.81 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $493.69 | 2024-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $478.64 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $415.71 | 2021-2025 | Jardiance |
| Boston Scientific Corporation | $290.04 | 2019-2024 | Emblem Mri S-Icd |
| Janssen Pharmaceuticals, INC | $278.96 | 2019-2022 | |
| Pfizer INC. | $271.33 | 2019-2025 | |
| Biotronik INC. | $230.91 | 2019-2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $226.59 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic Vascular, INC. | $177.30 | 2019-2020 | |
| Shockwave Medical, INC | $164.05 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $119.80 | 2020-2025 | Extended Holter, (Ck7) Extended Holter, (Ck4) Mcot |
| Chiesi USA, INC. | $99.13 | 2021-2022 | |
| Medtronic, INC. | $83.77 | 2021-2022 | |
| Irhythm Technologies, INC. | $51.27 | 2020-2021 | |
| Cvrx, INC. | $50.82 | 2024 | Barostim Neo System |
| Inspire Medical Systems, INC. | $48.71 | 2024-2025 | Inspire |
| Arbor Pharmaceuticals, INC. | $47.19 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $37.64 | 2019 | |
| Inari Medical, INC. | $36.58 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acacia Pharma INC | $34.46 | 2021 | |
| Cardiovascular Systems INC. | $33.93 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $33.91 | 2019-2020 | |
| Baxter Healthcare | $31.91 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardiva Medical, INC. | $31.07 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Teleflex LLC | $28.63 | 2020-2022 | |
| Ethicon US, LLC | $27.33 | 2022 | |
| Terumo Medical Corporation | $22.32 | 2022 | |
| Edwards Lifesciences Corporation | $21.07 | 2022 | |
| Biosense Webster, INC. | $18.13 | 2023 | Carto 3 |
| Gilead Sciences, INC. | $16.57 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.16 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.05 | 2019 | |
| Lilly USA, LLC | $13.84 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $13.06 | 2021 | |
| Siemens Medical Solutions USA, INC. | $11.76 | 2019 | |
| Cardinal Health 200 LLC | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Posligua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.